245 related articles for article (PubMed ID: 32299288)
21. Prognostic value of suPAR and hs-CRP on cardiovascular disease.
Diederichsen MZ; Diederichsen SZ; Mickley H; Steffensen FH; Lambrechtsen J; Sand NPR; Christensen KL; Olsen MH; Diederichsen A; Grønhøj MH
Atherosclerosis; 2018 Apr; 271():245-251. PubMed ID: 29402404
[TBL] [Abstract][Full Text] [Related]
22. The impact of renal function on the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with coronary artery disease.
Chen F; Li JQ; Ou YW; Xia TL; Huang FY; Chai H; Huang BT; Li Q; Pu XB; Li GY; Peng Y; Chen M; Huang DJ
Cardiol J; 2019; 26(6):696-703. PubMed ID: 29611168
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of soluble urokinase-type plasminogen activator receptor in coronary artery disease: A meta-analysis.
Li Y; Ding Y; Zhao Y; Gui Y; Shen Y; Xiang Q
Eur J Clin Invest; 2022 Dec; 52(12):e13867. PubMed ID: 36039688
[TBL] [Abstract][Full Text] [Related]
24. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
[TBL] [Abstract][Full Text] [Related]
26. Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
[TBL] [Abstract][Full Text] [Related]
27. Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients.
Wlazeł RN; Szadkowska I; Bartnicki P; Rośniak-Bąk K; Rysz J
Int Urol Nephrol; 2018 Feb; 50(2):339-345. PubMed ID: 29313168
[TBL] [Abstract][Full Text] [Related]
28. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
[TBL] [Abstract][Full Text] [Related]
29. Soluble Urokinase-Type Plasminogen Activator Receptor, Changes of 24-Hour Blood Pressure, and Progression of Chronic Kidney Disease.
Jhee JH; Nam BY; Lee CJ; Park JT; Han SH; Kang SW; Park S; Yoo TH
J Am Heart Assoc; 2021 Jan; 10(1):e017225. PubMed ID: 33325248
[TBL] [Abstract][Full Text] [Related]
30. Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients.
Huang Y; Zhou H; Wu Y; Yang Y; Li W; Lu J; Hu Y
Dis Markers; 2017; 2017():4719403. PubMed ID: 29109596
[TBL] [Abstract][Full Text] [Related]
31. Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.
Koller L; Stojkovic S; Richter B; Sulzgruber P; Potolidis C; Liebhart F; Mörtl D; Berger R; Goliasch G; Wojta J; Hülsmann M; Niessner A
JACC Heart Fail; 2017 Apr; 5(4):268-277. PubMed ID: 28359415
[TBL] [Abstract][Full Text] [Related]
32. Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study.
Rasmussen LJ; Knudsen A; Katzenstein TL; Gerstoft J; Obel N; Jørgensen NR; Kronborg G; Benfield T; Kjaer A; Eugen-Olsen J; Lebech AM
HIV Med; 2016 May; 17(5):350-7. PubMed ID: 26365671
[TBL] [Abstract][Full Text] [Related]
33. Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.
Sommerer C; Zeier M; Morath C; Reiser J; Scharnagl H; Stojakovic T; Delgado GE; März W; Kleber ME
Sci Rep; 2019 Jan; 9(1):475. PubMed ID: 30679668
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome.
Chenevier-Gobeaux C; Lemarechal H; Doumenc B; Peschanski N; Claessens YE; Borderie D; Ray P
Clin Biochem; 2021 Jun; 92():19-24. PubMed ID: 33662350
[TBL] [Abstract][Full Text] [Related]
35. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
36. Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery Disease.
Desai SR; Dhindsa DS; Ko YA; Sandesara PB; Mehta A; Liu C; Tahhan AS; Hayek SS; Ejaz K; Hooda A; Alkhoder A; Islam SJ; Rogers SC; Beshiri A; Murtagh G; Kim JH; Wilson P; Almuwaqqat Z; Sperling LS; Quyyumi AA
Am J Cardiol; 2023 Sep; 203():315-324. PubMed ID: 37517126
[TBL] [Abstract][Full Text] [Related]
37. Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score.
Dupuy AM; Kuster N; Bargnoux AS; Aguilhon S; Huet F; Leclercq F; Pasquié JL; Roubille F; Cristol JP
Clin Chem Lab Med; 2021 Jun; 59(7):1299-1306. PubMed ID: 33544524
[TBL] [Abstract][Full Text] [Related]
38. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
39. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects.
Sørensen MH; Gerke O; Eugen-Olsen J; Munkholm H; Lambrechtsen J; Sand NP; Mickley H; Rasmussen LM; Olsen MH; Diederichsen A
Atherosclerosis; 2014 Nov; 237(1):60-6. PubMed ID: 25222341
[TBL] [Abstract][Full Text] [Related]
40. Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.
Hjort M; Eggers KM; Lindhagen L; Agewall S; Brolin EB; Collste O; Daniel M; Ekenbäck C; Frick M; Henareh L; Hofman-Bang C; Malmqvist K; Spaak J; Sörensson P; Y-Hassan S; Tornvall P; Lindahl B
Clin Chem; 2019 Aug; 65(8):1023-1030. PubMed ID: 31072836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
